These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2119410)

  • 21. Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.
    Humphries JE; Acker MN; Pinkston JE; Ruddy S
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):372-6. PubMed ID: 7978060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric Castleman's disease with a lupus-like circulating anticoagulant.
    Yebra M; Vargas JA; Menéndez MJ; Cabrera JR; Díaz F; Diego FJ; Durántez A
    Am J Gastroenterol; 1989 May; 84(5):566-70. PubMed ID: 2497641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A circulating lupus-like coagulation inhibitor induced by chlorpromazine.
    Tollefson G; Rodysill K; Cusulos M
    J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
    Lockshin MD; Qamar T; Druzin ML; Goei S
    J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lupus anticoagulant antibody (LAC) and juvenile cerebral ischemic attack: a clinical case].
    Menabue R; Bonito V; Nichelli P
    Riv Neurol; 1989; 59(6):203-6. PubMed ID: 2517906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant in liver cirrhosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Balsano F
    Thromb Haemost; 1988 Apr; 59(2):335. PubMed ID: 3133815
    [No Abstract]   [Full Text] [Related]  

  • 27. The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay.
    Branch DW; Rote NS; Scott JR
    Clin Immunol Immunopathol; 1986 May; 39(2):298-307. PubMed ID: 3084145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transitions of each inhibitor in a patient with lupus anticoagulant and anti-prothrombin antibody].
    Murakami F; Iijima K; Nakamura K; Ikawa S; Hayashibara H; Siraki K
    Rinsho Byori; 1996 Jul; 44(7):692-6. PubMed ID: 8741501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal IgM with lupus anticoagulant activity in a case of Waldenström's macroglobulinaemia.
    Wisløff F; Michaelsen TE; Godal HC
    Eur J Haematol; 1987 May; 38(5):456-60. PubMed ID: 3115822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis I with unusual hypopigmentation masquerading as leprosy.
    Khandpur S; Malhotra AK; Deepak KK; Verma KK
    J Assoc Physicians India; 2004 Dec; 52():1001-3. PubMed ID: 15884465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postsurgical hemorrhage resulting from a drug-induced circulating anticoagulant: report of case.
    Nersasian RR; Rosner T; Gilmore W
    J Oral Surg; 1980 Sep; 38(9):688-90. PubMed ID: 6967961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP; Yen Y; Kriz NS; Breitenstein MG
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Budd-Chiari syndrome in a patient with the lupus anticoagulant.
    Pomeroy C; Knodell RG; Swaim WR; Arneson P; Mahowald ML
    Gastroenterology; 1984 Jan; 86(1):158-61. PubMed ID: 6416918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time.
    Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M
    Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.